Acquired hepatocerebral degeneration;Degeneración hepatocerebral adquirida

Revista de Neurologia

Volumn 48, Issue 5, 2009, Pages 274-276

  Duran Ferreras E ^a,b   Robledo Strauss, A ^a   Diaz Espejo C ^a  

^a HOSPITAL JUAN RAMÓN JIMÉNEZ   (Spain)

^b NONE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; CASE REPORT; CLINICAL FEATURE; FEMALE; HEPATIC ENCEPHALOPATHY; HUMAN; LETTER; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; WILSON DISEASE; DIFFERENTIAL DIAGNOSIS; PATHOLOGY;

AGED; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEPATOLENTICULAR DEGENERATION; HUMANS;

EID: 63149129179     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.4805.2008523     Document Type: Letter

References (26)

1. Van Woerkom W. La cirrhose hépatique avec altérations dans les centres nerveux évoluant chez des sujets d'âge moyen. Nouvelle iconographie de la Salpetrie. Clin Maladies Système Nerveux 1914; 7: 41-51.
2. Jog MS, Lang AE. Chronic acquired hepatocerebral degeneration: case reports and new insights. Mov Disord 1995; 10: 714-22.
3. Kulisevsky J, Ruscalleda J, Grau JM. MR imaging of acquired hepatocerebral degeneration. AJNR Am J Neuroradiol 1991; 12: 527-8.
4. Stracciari A, Mattarozzi K, D'Alessandro R, Baldin E, Guarino M. Cognitive functioning in chronic acquired hepatocerebral degeneration. Metab Brain Dis 2008; 23: 155-60.
5. Lewis MB, MacQuillan G, Bamford JM, Howdle PD. Delayed myelopathic presentation of the acquired hepatocerebral degeneration syndrome. Neurology 2000; 54: 1011.
6. Park SA, Heo K. Prominent cerebellar symptoms with unusual magnetic resonance imaging findings in acquired hepatocerebral degeneration. Arch Neurol 2004; 61: 1458-60.
7. Burkhard PR, Delavelle J, Du Pasquier R, Spahr L. Chronic parkinsonism associated with cirrhosis: a distinct subset of acquired hepa-tocerebral degeneration. Arch Neurol 2003; 60: 521-8.
8. Ferrara J, Gupta D, Foster E, Garman K, Stacy M. Extraocular muscle dystonia due to acquired (non-Wilsonian) hepatocerebral degeneration. Mov Disord 2008; 23: 875-8.
9. Miranda M, Caballero L. Chronic hepatic encephalopathy: the role of high serum manganese levels and its relation with basal ganglia lesions in nuclear magnetic resonance of the brain. Clinical case. Rev Med Chil 2001; 129: 1051-5.
10. Sinha S, Taly AB, Ravishankar S, Prashanth LK, Venugopal KS, Arunodaya GR, et al. Wilson's disease: cranial MRI observations and clinical correlation. Neuroradiology 2006; 48: 613-21.
11. Cakirer S, Karaarslan E, Arslan A. Spontaneously T1-hyperintense lesions of the brain on MRI: a pictorial review. Curr Probl Diagn Radiol 2003; 32: 194-217.
12. Hanner JS, Li KC, Davis GL. Acquired hepatocerebral degeneration: MR similarity with Wilson disease. J Comput Assist Tomogr 1988; 12: 1076-7.
13. Pujol A, Pujol J, Graus F, Rimola A, Peri J, Mercader JM, et al. Hyperintense globus pallidus on T1-weighted MRI in cirrhotic patients is associated with severity of liver failure. Neurology 1993; 43: 65-9.
14. Pabón V, Dumortier J, Gincul R, Baulieux J, Ducerf C, Trépo C, et al. Long-term results of liver transplantation for Wilson's disease. Gastroenterol Clin Biol 2008; 32: 378-81.
15. Servin-Abad L, Tzakis A, Schiff ER, Regev A. Acquired hepatocerebral degeneration in a patient with HCV cirrhosis: complete resolution with subsequent recurrence after liver transplantation. Liver Transpl 2006; 12: 1161-5.
16. Pinarbasi B, Kaymakoglu S, Matur Z, Akyuz F, Demir K, Besisik F, et al. Are acquired hepatocerebral degeneration and hepatic myelopathy reversible? J Clin Gastroenterol 2008; Aug 11 [Epub ahead of print]
17. Papapetropoulos S, Tzakis A, Sengun C, Reddy C, Boukas K, Zitser J, et al. Case of pediatric acquired chronic hepatocerebral degeneration. Pediatr Neurol 2008; 38: 67-70.
18. Papapetropoulos S, Singer C. Management of the extrapyramidal syndrome in chronic acquired hepatocerebral degeneration (CAHD). Mov Disord 2005; 20: 1088-9.
19. Krieger D, Krieger S, Jansen O, Gass P, Theilmann L, Lichtnecker H. Manganese and chronic hepatic encephalopathy. Lancet 1995; 346: 270-4.
20. Martín-Romano L, Alfredo-Femminini R. Degeneración hepatocerebral crónica adquirida. Presentación de dos casos. Neurología 2007; 22: 391-4.
21. Khan FS, Ashalatha R. Acquired (non-Wilsonian) hepatocerebral degeneration. Neurol India 2004; 52: 527.
22. Saito H, Ejima A. Liver dysfunction and probable manganese accumulation in the brainstem and basal ganglia. J Neurol Neurosurg Psychiatry 1995; 58: 760-1.
23. Albrecht J, Jones EA. Hepatic encephalopathy: molecular mechanisms underlying the clinical syndrome. J Neurol Sci 1999; 170: 138-46.
24. Norenberg MD, Neary JT, Bender AS, Dombro RS. Hepatic encephalopathy: a disorder in glial-neuronal communication. Prog Brain Res 1992; 94: 261-9.
25. Mousseau DD, Perney P, Layrargues GP, Butterworth RF. Selective loss of pallidal dopamine D2 receptor density in hepatic encephalopathy. Neurosci Lett 1993; 162: 192-6.
26. Chen WX, Wang P, Yan SX, Li YM, Yu CH, Jiang LL. Acquired hepatocerebral degeneration: a case report. World J Gastroenterol 2005; 11: 764-6.